Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT03243812
Eligibility Criteria:
Inclusion Criteria:
For Sickle cell patients :
* age ≥ 15 and \< 60 years old,
* SS homozygote or SC heterozygote
* in clinical steady state (i.e. without vaso-occlusive crisis or recent blood transfusion)
* identified by systematic neonatal screening programs,
* registered in the French medical social security national program
For Healthy and non sickle cell subjects:
* age ≥ 18 and \< 60 years old
* without cardiovascular/respiratory/muscle disease,
* registered in the French medical social security national program.
Exclusion Criteria:
* other hemoglobinopathies,
* stroke or vasculopathy history,
* presence of leg ulcers or osteonecrosis,
* recent infectious episode (less than 1 month),
* chronic transfusion therapy programs,
* recent blood transfusion or phlebotomies (less than 3 months),
* patients not at steady state,
* pregnancy or breast feeding
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
60 Years
Study:
NCT03243812
Study Brief:
Protocol Section:
NCT03243812